On bringing breakthrough medicines and technologies to patients.  Based near Paris, iXLife Capital identifies, evaluates, invests in, and supports biotech companies that take creative approaches to developing important new therapies and devices for cancer, neurologic, and other diseases and conditions.

Managing Partner / Jean-Pierre Kinet